Reynolds American Inc. on Monday cleared the final hurdle for its $25 billion acquisition of Lorillard Inc. as a federal judge granted approval allowing the company to go forward with its plan to divest several cigarette brands.
US District Judge Gladys Kessler of Washington, DC, granted a motion that will allow Reynolds to divest Maverick, Kool, Salem and Winston cigarette brands to Imperial Tobacco Group PLC. The divestiture of those brands, which will cost Imperial $7.1 billion, was critical to Federal Trade Commission approval of the deal.
The companies needed judicial approval for that divestiture because they are subject to a nearly decade-old civil judgment in a government racketeering case that requires they obtain court permission before they can divest cigarette brands.
Reynolds and Lorillard announced their planned marriage last July. The agreement included the Imperial divestiture, which was designed to head off concerns the merger would hurt competition and lead to higher prices.
The FTC, which spent nearly a year scrutinizing the deal, granted approval for it late last month. Reynolds has said it expects to close the deal in June.
Full content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Extends Support for Farms and Fisheries Amid Market Disruptions
May 5, 2024 by
CPI
Sony and Apollo Bid $26 Billion for Paramount Acquisition
May 5, 2024 by
CPI
Goldman Sachs Resolves Decade-Old Metal-Rigging Class Action Lawsuit
May 5, 2024 by
CPI
Italian Antitrust Ruling Puts Halt on Intesa Sanpaolo’s Fintech Ambitions
May 5, 2024 by
CPI
Google Antitrust Case: Closing Arguments Conclude
May 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI